Chloe Botaine

The intricate and often confusing landscape of prescription drug costs is on the verge of a significant transformation, driven by landmark federal initiatives poised to reshape the pharmacy benefit management (PBM) industry. For years, group health plan sponsors have navigated a complex system with

A father’s deeply personal struggle to secure mental health support for his child has ignited a nationwide movement, exposing what advocates call a catastrophic failure within the United Kingdom's publicly funded services for young people. Tom Tunney of Thatcham, driven by his family's nearly

A landmark formal partnership between the California Institute of Technology and Cedars-Sinai Health Sciences University promises to dissolve the traditional barriers that often separate fundamental scientific research from its practical application in patient care. This strategic alliance,

The loss of an adult tooth has long been considered a permanent event, a problem addressed only by synthetic replacements like dentures or implants that, while functional, are not a true biological restoration. However, a revolutionary wave of research emerging from Japan is challenging this

A landmark federal funding package signed into law on February 3, 2026, aims to permanently alter the landscape of American healthcare by addressing two of its most pressing challenges: the accessibility of care and the spiraling cost of prescription drugs. This pivotal legislation, which secured

A ransomware attack on a hospital is no longer a distant headline; it is a direct and immediate threat that can grind patient care to a halt, forcing emergency rooms to divert ambulances, postponing critical surgeries, and severing access to vital medical records. The conversation surrounding

An Industry in Transformation: Decoding the M&A Boom The healthcare sector is currently in the midst of a transformative wave of consolidation, marked by a significant uptick in both traditional mergers and strategic acquisitions focused on artificial intelligence. This surge reflects a dynamic

A federal jury has delivered a verdict that sends shockwaves not just through the medical device industry but across the landscape of corporate competition, handing down a penalty worth over a third of a billion dollars not for a faulty product but for the way it was sold. This case highlights how

A significant transformation is underway within the financial corridors of American hospitals, as the primary drivers of supply chain inflation are pivoting away from the long-standing concern of pharmaceutical prices toward the rapidly escalating costs of technology and purchased services. A

For the ever-expanding community of individuals navigating life after a cancer diagnosis, dietary choices have long been recognized as a cornerstone of maintaining long-term health and mitigating the risk of recurrence. While conventional wisdom has traditionally emphasized the balance of